Literature DB >> 4053357

An automated liquid-chromatographic system for convenient determination of glycated hemoglobin A1c.

A K Saleh, M A Moussa.   

Abstract

For quantification of glycated hemoglobin (HbA1c), we compared an automated system (Pharmacia Fast Protein Liquid Chromatography), which separates and determines HbA1c, with a commercial disposable-minicolumn kit (Boehringer-Mannheim), which separates total HbA1. We studied 41 diabetic women and 79 apparently normal women on their first postparturition day. The automated method was more precise (within-run CV 0.98-4.16%) than the kit method (within-run CV 3.67-7.77%). Results by the two methods correlated well for both control (p less than 0.001) and diabetic (p less than 0.05) groups. Values for HbA1c correlated significantly with fasting blood-glucose concentrations in controls and diabetics (intraclass correlation coefficient rI = 0.822 and 0.851, respectively, p less than 0.001) as well as with 1- and 2-h values for glucose after a 75-g glucose load in the control group (rI = 0.649 and 0.846, respectively, p less than 0.001). For HbA1 no such significant correlation was found except with values for fasting blood glucose in diabetics (rI = 0.745, p less than 0.001). Evaluation of HbA1c was a more sensitive index of glycemic status. The automated system is convenient, reliable, and easily operated.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4053357

Source DB:  PubMed          Journal:  Clin Chem        ISSN: 0009-9147            Impact factor:   8.327


  3 in total

1.  Engineering a protease-based and site-specific PEGylation-based strategy for the controlled release of exenatide.

Authors:  Aihong Zhang; Yin Lin; Shirly Nong; Wei Zhao; Mei Dong
Journal:  RSC Adv       Date:  2020-06-30       Impact factor: 4.036

2.  Novel fatty chain-modified GLP-1R G-protein biased agonist exerts prolonged anti-diabetic effects through targeting receptor binding sites.

Authors:  Maorong Wang; Ping Yao; Minpeng Gao; Jian Jin; Yerong Yu
Journal:  RSC Adv       Date:  2020-02-24       Impact factor: 4.036

3.  Design and evaluation of novel thrombin-based GLP-1 analogs with peptidic albumin binding domain for the controlled release of GLP-1.

Authors:  Xianli Niu; Shirong Nong; Xiaomin Zhang; Xiangyang Li; Cheng Wang; Wei Li; Tianhong Zhou
Journal:  RSC Adv       Date:  2020-01-29       Impact factor: 4.036

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.